Evrofarma Viomichania Galaktos Anonymi Viomichaniki & Emporiki Etaireia SA

Evrofarma maintains a debt-to-equity ratio of 0.83 and a current ratio of 2.23, indicating moderate leverage and strong short-term liquidity. The company holds 6.56 million EUR in cash and equivalents, but its long-term debt of 17.06 million EUR suggests a need for careful capital structure management. Free cash flow of 1.22 million EUR supports operational flexibility, though capital expenditures of -4.32 million EUR indicate recent investment activity. Profitability metrics show a return on equity of 17.07% and a return on assets of 6.26%, which are strong relative to the Food Processing industry. Gross profit of 18.55 million EUR on 49.44 million EUR in revenue reflects a gross margin of 37.5%, suggesting efficient cost control. However, operating income of 5.22 million EUR and net income of 3.53 million EUR indicate a need for continued cost optimization to maintain margins. The company's revenue is concentrated in Greece, with no disclosed international operations. Its wholly owned subsidiary, Campus SA, is a key contributor to cow milk production, but the lack of geographic diversification increases exposure to local economic and regulatory conditions. Growth trajectory appears modest, with recent revenue of 49.44 million EUR and a net income of 3.53 million EUR. Analyst estimates for the last actual revenue and EPS were 26.81 million EUR and 0.02 EUR, respectively, suggesting a potential for growth in the coming fiscal year. However, the company's capital expenditures and debt levels may constrain near-term expansion. Risk factors include medium liquidity risk due to negative net cash after subtracting total debt, and low dilution risk. The company's reliance on local dairy suppliers and the absence of international diversification could pose operational and regulatory risks. No significant dilution sources are identified in the latest filings. Recent events include the latest financial filings and analyst estimates, which show a stable but not accelerating performance. The company's focus on core dairy products and its subsidiary Campus SA remain central to its operations. No major strategic shifts or new product launches have been disclosed in the latest reports.